Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
10,835,771
-
Share change
-
-177,984
-
Total reported value
-
$180,597,000
-
Price per share
-
$16.67
-
Number of holders
-
36
-
Value change
-
-$5,671,266
-
Number of buys
-
19
-
Number of sells
-
19
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q2 2015
As of 30 Jun 2015,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,835,771 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, JENNISON ASSOCIATES LLC, JANUS CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Viking Global Investors LP, Redmile Group, LLC, Clearbridge Investments, LLC, and FRANKLIN RESOURCES INC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.